News from Quartz
What is your interest today?
Bitcoin
Crypto
Btc
Ceo
Tariffs
Stocks
Investors
Shares
Crypto Assets
Stock
Cryptocurrency
Stock Market
Ethereum
Price
Markets
Xrp
Investment
Stablecoin
Blockchain
Etf
Sec
Eth
Bse
Ipo
Trade
Index
Solana
Earnings
Revenue
Inflation
China
Coinbase
Interest Rates
Token
Wall Street
Nasdaq
Sensex
Gold
Federal Reserve
Usd
Treasury
Traders
Economy
Nse
Trade War
Bse Sensex
Tesla
Profit
Digital Assets
Sp 500
Buy
Governments
Inheritance Tax
Xapo Bank
Medici
Draft Bill
Bitnile
Ai Hardware
Metals Focus
Peter Lynch
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
Quartz • Jun 16, 2025
A $250 mistake seems set to cost Ozempic maker Novo Nordisk billions
Novo Nordisk is expected to face substantial financial losses as Canada prepares to introduce generic alternatives of its weight loss medication due to the company’s failure to mai...
Read Full Article →